UNLIMITED TURBO LONG - UCB Stock

XA0IB

NLBNPNL223L1

Real-time Euronext Paris 08:18:26 2024-05-07 EDT
12.84 ^EUR	+1.10%

Current month	-7.67%
1 month	+9.62%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

UCB - Acquisition of own shares	05-06	AQ
UCB : Acquisition of own shares	04-26	PU
Pioneering innovation, fueling growth: UCB's commitment to delivering differentiated solutions	04-26	PU
Ex-dividend day for final dividend	04-25	FA

More news

Quotes 5-day view

Date	Price	Change	Volume
24-05-07	12.84	+1.10%	57
24-05-06	12.7	-2.01%	87
24-05-03	12.96	-2.04%	99
24-05-02	13.23	-3.82%	111
24-04-30	13.76	+1.25%	89

Real-time Euronext Paris

Last update May 07, 2024 at 08:18 am

More quotes

Static data

Product type	Knock-Out without Stop Loss
Buy / Sell	CALL
Underlying	UCB
Issuer	BNP Paribas
	XA0IB
ISIN	NLBNPNL223L1
Date issued	2022-09-23
Strike	57.16 €
Maturity	Unlimited
Parity	5 : 1
Emission price	2.85 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	13.84 €
Lowest since issue	2.02 €
Spread	0.02 €
Spread %	0.16%

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

119.3 EUR

Average target price

125.5 EUR

Spread / Average Target

+5.19%

Consensus